P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication — Stella

Home/Helicobacter Pylori Infection/

View on ClinicalTrials.gov

Recruiting

Back to Helicobacter Pylori Infection trials

Trial locations(1 site)

China

Qilu Hospital of Shandong University, Jinan

Key details

Sponsor

Yueyue Li

Collaborators

Qilu Hospital of Shandong University, Feicheng People's Hospital

Enrollment target

~1,730 participants

Started

December 2025

Primary completion

June 2026

Age range

18 Years – 70 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.